Back
Journey Medical Vs. Outlook Therapeutics Industry Stock Comparison
Buy
65
DERM
Journey Medical
Last Price:
3.60
Seasonality Move:
12.92%
Sell
47
OTLK
Outlook Therapeutics
Last Price:
7.91
Seasonality Move:
-0.16%
Buy
65
Journey Medical (DERM)
is a Buy
Is Journey Medical a Buy, Sell or Hold?
- The current Journey Medical [DERM] share price is $3.60. The Score for DERM is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
- DERM is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
47
Outlook Therapeutics (OTLK)
is a Sell
Is Outlook Therapeutics a Buy, Sell or Hold?
- The current Outlook Therapeutics [OTLK] share price is $7.90. The Score for OTLK is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
- OTLK is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
DERM Stock Price Chart
What is Journey Medical's stock price today?
-
The Journey Medical share price today is $3.60
The current trend is relatively stagnant and DERM is experiencing slight buying pressure.
OTLK Stock Price Chart
What is Outlook Therapeutics's stock price today?
-
The Outlook Therapeutics share price today is $7.90
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and OTLK is experiencing buying pressure, which is a positive indicator for future bullish movement.
DERM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.04 | Sell |
| Relative Strength Index (14 RSI): | 50.68 | Buy |
| Chaikin Money Flow: | 15120 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.43 - 3.63) | Buy |
| Bollinger Bands (100): | (3.4 - 4.72) | Sell |
OTLK Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.2 | Sell |
| Relative Strength Index (14 RSI): | 47.8 | Sell |
| Chaikin Money Flow: | 188145 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (7.6 - 8.52) | Sell |
| Bollinger Bands (100): | (7.38 - 9.06) | Sell |
DERM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.52 | Buy |
| 20-day SMA: | 3.55 | Buy |
| 50-day SMA: | 3.65 | Sell |
| 200-day SMA: | 3.89 | Sell |
| 8-day EMA: | 3.54 | Buy |
| 20-day EMA: | 3.56 | Buy |
| 50-day EMA: | 3.7 | Sell |
| 200-day EMA: | 3.73 | Sell |
OTLK Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 7.72 | Buy |
| 20-day SMA: | 8.02 | Sell |
| 50-day SMA: | 8.43 | Sell |
| 200-day SMA: | 9.24 | Sell |
| 8-day EMA: | 7.79 | Buy |
| 20-day EMA: | 7.95 | Sell |
| 50-day EMA: | 8.2 | Sell |
| 200-day EMA: | 11.16 | Sell |
Journey Medical Earnings Growth & DERM Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Outlook Therapeutics Earnings Growth & OTLK Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.23 per share, an increase next quarter of $0.38 per share, an increase this year of $0.74 per share, and an increase next year of $1.74 per share.
Journey Medical Technical Analysis
| May 13 | May 14 | May 15 | May 16 | May 17 | May 20 | May 21 | May 22 | May 23 | May 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 13 | 14 | 15 | 16 | 17 | 20 | 21 | 22 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Outlook Therapeutics Technical Analysis
| May 13 | May 14 | May 15 | May 16 | May 17 | May 20 | May 21 | May 22 | May 23 | May 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 13 | 14 | 15 | 16 | 17 | 20 | 21 | 22 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||